{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:15:47Z","timestamp":1791983747276,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:00:00Z","timestamp":1328572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00432-012-1161-y","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T02:26:35Z","timestamp":1328495195000},"page":"867-875","source":"Crossref","is-referenced-by-count":20,"title":["Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers"],"prefix":"10.1007","volume":"138","author":[{"given":"Ana","family":"Custodio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"L\u00f3pez-Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Zamorano-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J.","family":"Mateos-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Cald\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"de la Hoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"D\u00edaz-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"P\u00e9rez-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,7]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/pr060159w","volume":"5","author":"S Alonso-Orgaz","year":"2006","unstructured":"Alonso-Orgaz S, Moreno L, Macaya C, Rico L, Mateos-C\u00e1ceres PJ, Sacrist\u00e1n D, P\u00e9rez-Vizca\u00edno F, Segura A, Tamargo J, L\u00f3pez-Farr\u00e9 A (2006) Proteomic study of plasma from moderate hypercholesterolemic patients. J Proteome Res 5:2301\u20132308. doi: 10.1021\/pr060159w","journal-title":"J Proteome Res"},{"key":"1161_CR2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4149\/neo_2010_04_333","volume":"57","author":"LM Berstein","year":"2010","unstructured":"Berstein LM, Koskela A, Boyarkina MP, Adlercreutz H (2010) Excretion of estrogens, catecholestrogens and phytoestrogens in carriers of BRCA1 gene mutations: effects of metformin. Neoplasma 57:333\u2013338. doi: 10.4149\/neo_2010_04_333","journal-title":"Neoplasma"},{"key":"1161_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMp030086","volume":"349","author":"RL Bick","year":"2003","unstructured":"Bick RL (2003) Cancer-associated thrombosis. N Engl J Med 349:109\u2013111","journal-title":"N Engl J Med"},{"key":"1161_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.187.3.329","volume":"187","author":"T Bombeli","year":"1998","unstructured":"Bombeli T, Schwartz BR, Harlan JM (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187:329\u2013339. doi: 10.1084\/jem.187.3.329","journal-title":"J Exp Med"},{"key":"1161_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1745-7599.2009.00486.x","volume":"22","author":"L Bourdeanu","year":"2010","unstructured":"Bourdeanu L, Luu T (2010) Arterial thrombosis associated with adjuvant chemotherapy for breast cancer: a case report. J Am Acad Nurse Pract 22:140\u2013143. doi: 10.1111\/j.1745-7599.2009.00486.x","journal-title":"J Am Acad Nurse Pract"},{"key":"1161_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005792-199805000-00006","volume":"77","author":"LC Brody","year":"1998","unstructured":"Brody LC, Biesecker BB (1998) Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine (Baltimore) 77:208\u2013226","journal-title":"Medicine (Baltimore)"},{"key":"1161_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(92)80156-B","volume":"300","author":"N Bucurenci","year":"1992","unstructured":"Bucurenci N, Blake DR, Chidwick K, Winyard PG (1992) Inhibition of neutrophil superoxide production by human plasma a1-antitrypsin. FEBS Lett 300:321. doi: 10.1016\/0014-5793(92)80156-B","journal-title":"FEBS Lett"},{"issue":"Suppl","key":"1161_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2007.02497.x","volume":"1","author":"HR Buller","year":"2007","unstructured":"Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW (2007) Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 1(Suppl):246\u2013254. doi: 10.1111\/j.1538-7836.2007.02497.x","journal-title":"J Thromb Haemost"},{"key":"1161_CR9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analyisis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333. doi: 10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"key":"1161_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1097-0215(20010101)91:1<137::AID-IJC1020>3.0.CO;2-R","volume":"91","author":"M Hoya de la","year":"2001","unstructured":"de la Hoya M, P\u00e9rez-Segura P, Van Orsouw N, D\u00edaz-Rubio E, Cald\u00e9s T (2001) Spanish family study on hereditary breast and\/or ovarian cancer: analysis of the BRCA1 gene. Int J Cancer 91:137\u2013140. doi: 10.1002\/10970215(20010101)91:1<137:AID-IJC1020>3.0.CO;2-R","journal-title":"Int J Cancer"},{"key":"1161_CR11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.1627","volume":"97","author":"M Hoya de la","year":"2002","unstructured":"de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodr\u00edguez R, D\u00edaz-Rubio E, Ben\u00edtez J, Devilee P, Cald\u00e9s T (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466\u2013471. doi: 10.1002\/ijc.1627","journal-title":"Int J Cancer"},{"key":"1161_CR12","doi-asserted-by":"crossref","unstructured":"Defeo K, Hayes C, Chernick M, Van Ryn J, Gilmour SK (2010) Use of dabigatran etexilate to reduce breast cancer progression. Cancer Biol Ther. doi: 10.4161\/cbt.10.10.13236","DOI":"10.4161\/cbt.10.10.13236"},{"key":"1161_CR13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/nar\/gkl010","volume":"34","author":"CX Deng","year":"2006","unstructured":"Deng CX (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34:1416\u20131426. doi: 10.1093\/nar\/gkl010","journal-title":"Nucleic Acids Res"},{"key":"1161_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/1055-9965.EPI-08-0653","volume":"18","author":"H Dieplinger","year":"2009","unstructured":"Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L, Buchner H, Stieber P (2009) Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol Biomarkers Prev 18:1127\u20131133. doi: 10.1158\/1055-9965.EPI-08-0653","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1161_CR15","first-page":"1457","volume":"57","author":"D Ford","year":"1995","unstructured":"Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457","journal-title":"Am J Hum Genet"},{"key":"1161_CR16","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","volume":"27","author":"D Gailani","year":"2007","unstructured":"Gailani D, Renn\u00e9 T (2007) Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 27:2507\u20132513","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1161_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-008-0263-3","volume":"116","author":"MC Gast","year":"2009","unstructured":"Gast MC, Schellens JH, Beijnen JH (2009) Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat 116:17\u201329. doi: 10.1007\/s10549-008-0263-3","journal-title":"Breast Cancer Res Treat"},{"key":"1161_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MPA.0b013e3181987d86","volume":"38","author":"Q Guo","year":"2009","unstructured":"Guo Q, Zhang B, Dong X, Wu Y (2009) Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas 38:75\u201379. doi: 10.1097\/MPA.0b013e3181987d86","journal-title":"Pancreas"},{"key":"1161_CR19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","volume":"118","author":"TC Haddad","year":"2006","unstructured":"Haddad TC, Greeno EW (2006) Chemotherapy-induced thrombosis. Thromb Res 118:555\u2013568","journal-title":"Thromb Res"},{"key":"1161_CR20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1523-1755.2005.00519.x","volume":"68","author":"M Haiman","year":"2005","unstructured":"Haiman M, Salvenmoser W, Scheiber K, Lingenhel A, Rudolph C, Schmitz G, Kronenberg F, Dieplinger H (2005) Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney Int 68:1130\u20131136. doi: 10.1111\/j.1523-1755.2005.00519.x","journal-title":"Kidney Int"},{"key":"1161_CR21","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684\u20131689","journal-title":"Science"},{"key":"1161_CR22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0090-4295(03)00036-0","volume":"61","author":"JJ Hlavaty","year":"2003","unstructured":"Hlavaty JJ, Partin AW, Shue MJ, Mangold LA, Derby J, Javier T, Kelley S, Stieg A, Briggman JV, Hass GM, Wu YJ (2003) Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer. Urology 61:1261\u20131265. doi: 10.1016\/S0090-4295(03)00036-0","journal-title":"Urology"},{"key":"1161_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2006.03.012","volume":"53","author":"JM Jones","year":"2006","unstructured":"Jones JM, McGonigle NC, McAnespie M, Cran GW, Graham AN (2006) Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer 53:97\u2013101. doi: 10.1016\/j.lungcan.2006.03.012","journal-title":"Lung Cancer"},{"key":"1161_CR24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(02)11087-7","volume":"360","author":"RD Kennedy","year":"2002","unstructured":"Kennedy RD, Quinn JE, Johnston PG, Harkin DP (2002) BRCA1: mechanisms of inactivation and implications for management of patients. Lancet 360:1007\u20131014. doi: 10.1016\/S0140-6736(02)11087-7","journal-title":"Lancet"},{"key":"1161_CR25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-5699(91)90001-A","volume":"12","author":"T Kinoshita","year":"1991","unstructured":"Kinoshita T (1991) Biology of complement: the overture. Immunol Today 12:291\u2013295","journal-title":"Immunol Today"},{"key":"1161_CR26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1078-0432.1110.11.3","volume":"11","author":"JM Koomen","year":"2005","unstructured":"Koomen JM, Shih LN, Coombes KR, Li D, Xiao LC, Fidler IJ, Abbruzzese JL, Kobayashi R (2005) Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 11:1110\u20131118","journal-title":"Clin Cancer Res"},{"key":"1161_CR27","first-page":"371","volume":"25","author":"K Kumar","year":"1991","unstructured":"Kumar K, Thangaraju M, Sachdanandam P (1991) Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochem Int 25:371\u2013380","journal-title":"Biochem Int"},{"key":"1161_CR28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/clinchem\/48.8.1296","volume":"48","author":"J Li","year":"2002","unstructured":"Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296\u20131304","journal-title":"Clin Chem"},{"key":"1161_CR29","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1373\/clinchem.2005.052878","volume":"51","author":"J Li","year":"2005","unstructured":"Li J, Orlandi R, White CN, Rosenzweig J, Zhao J, Seregni E, Morelli D, Yu Y, Meng XY, Zhang Z, Davidson NE, Fung ET, Chan DW (2005) Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem 51:2229\u20132235","journal-title":"Clin Chem"},{"key":"1161_CR30","first-page":"167","volume":"5","author":"A L\u00f3pez-Farr\u00e9","year":"2010","unstructured":"L\u00f3pez-Farr\u00e9 A, Zamorano-Le\u00f3n JJ (2010) The contribution of proteomics to cancer diagnosis. Cancer Chemother 5:167\u2013176","journal-title":"Cancer Chemother"},{"key":"1161_CR31","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/pr060600i","volume":"6","author":"AJ L\u00f3pez-Farr\u00e9","year":"2007","unstructured":"L\u00f3pez-Farr\u00e9 AJ, Mateos-C\u00e1ceres PJ, Sacrist\u00e1n D, Azcona L, Bernardo E, de Prada TP, Alonso-Orgaz S, Fern\u00e1ndez-Arquero M, Fern\u00e1ndez-Ortiz A, Macaya C (2007) Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res 6:2481\u20132487. doi: 10.1021\/pr060600i","journal-title":"J Proteome Res"},{"issue":"Suppl A","key":"1161_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurheartj\/16.suppl_A.25","volume":"16","author":"PM Mannucci","year":"1995","unstructured":"Mannucci PM (1995). Recent progress in the pathophysiology of fibrinogen. Eur Heart J 16(Suppl A):25\u201330. doi: 10.1093\/eurheartj\/16.suppl_A.25","journal-title":"Eur Heart J"},{"key":"1161_CR33","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2004.06.073","volume":"44","author":"PJ Mateos-C\u00e1ceres","year":"2004","unstructured":"Mateos-C\u00e1ceres PJ, Garc\u00eda-M\u00e9ndez A, L\u00f3pez Farr\u00e9 A, Macaya C, N\u00fa\u00f1ez A, G\u00f3mez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andr\u00e9s R, Granizo JJ, Farr\u00e9 J, Rico LA (2004) Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 44:1578\u20131583. doi: 10.1016\/j.jacc.2004.06.073","journal-title":"J Am Coll Cardiol"},{"key":"1161_CR34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1160\/TH09-05-0290","volume":"103","author":"PJ Mateos-C\u00e1ceres","year":"2010","unstructured":"Mateos-C\u00e1ceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E, Fernandez-Ortiz A, L\u00f3pez-Farr\u00e9 AJ (2010) Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost 103:160\u2013170. doi: 10.1160\/TH09-05-0290","journal-title":"Thromb Haemost"},{"key":"1161_CR35","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1182\/blood-2010-06-293126","volume":"116","author":"TA McEachron","year":"2010","unstructured":"McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N (2010) Protease-activated receptors mediate cross-talk between coagulation and fibrinolysis. Blood 116:5037\u20135044. doi: 10.1182\/blood-2010-06-293126","journal-title":"Blood"},{"key":"1161_CR36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.bjc.6605413","volume":"101","author":"M Mego","year":"2009","unstructured":"Mego M, De Giorgi U, Broglio K, Dawood S, Valero V, Andreopoulou E, Handy B, Reuben JM, Cristofanilli M (2009) Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. Br J Cancer 101:1813\u20131816. doi: 10.1038\/sj.bjc.6605413","journal-title":"Br J Cancer"},{"key":"1161_CR37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran CL, Bennett M, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"1161_CR38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.pharmthera.2006.01.001","volume":"111","author":"VM Miller","year":"2006","unstructured":"Miller VM, Jayachandran M, Heit JA, Owen WG (2006) Estrogen therapy and thrombotic risk. Pharmacol Ther 111:792\u2013807","journal-title":"Pharmacol Ther"},{"key":"1161_CR39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1540-8167.2010.01718.x","volume":"21","author":"J Modrego","year":"2010","unstructured":"Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-C\u00e1ceres P, Segura A, Moreno-Herrero R, P\u00e9rez-Castellanos N, Delp\u00f3n E, P\u00e9rez-Villacast\u00edn J, Rodr\u00edguez E, Macaya C, L\u00f3pez-Farr\u00e9 AJ (2010) Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation. J Cardiovasc Electrophysiol 21:859\u2013868. doi: 10.1111\/j.1540-8167.2010.01718.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1161_CR40","first-page":"62","volume":"2","author":"M Nagulu","year":"2009","unstructured":"Nagulu M, Uday KV, Nalini K, Dharak R, Narsimha RY, Rama KD (2009) Oxidative stress and anti-oxidant status in breast cancer patients. J Pharm Res 2:62\u201365","journal-title":"J Pharm Res"},{"key":"1161_CR41","first-page":"54","volume":"6","author":"S Nand","year":"1993","unstructured":"Nand S (1993) Homeostasis and cancer. Cancer J 6:54\u201358","journal-title":"Cancer J"},{"key":"1161_CR42","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","volume":"339","author":"CK Osborne","year":"1998","unstructured":"Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609\u20131618","journal-title":"N Engl J Med"},{"key":"1161_CR43","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.21.6.1023","volume":"21","author":"MA Ostos","year":"2001","unstructured":"Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, Girona J, Caillaud JM, Ochoa A, Zakin MM (2001) Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Bio 21:1023\u20131028. doi: 10.1161\/01.ATV.21.6.1023","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"1161_CR44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1634\/theoncologist.2009-0079","volume":"14","author":"S Polterauer","year":"2009","unstructured":"Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L (2009) Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 14:979\u2013985. doi: 10.1634\/theoncologist.2009-0079","journal-title":"Oncologist"},{"key":"1161_CR45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF01247464","volume":"120","author":"K Punnonen","year":"1994","unstructured":"Punnonen K, Ahotupa M, Asaishi K, Hy\u00f6ty M, Kudo R, Punnonen R (1994) Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Onco 120:374\u2013377. doi: 10.1007\/BF01247464","journal-title":"J Cancer Res Clin Onco"},{"key":"1161_CR46","first-page":"H1836","volume":"274","author":"X Qin","year":"1998","unstructured":"Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P (1998) Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol 274:H1836\u2013H1840","journal-title":"Am J Physiol"},{"key":"1161_CR47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V62.1.14.14","volume":"62","author":"FR Rickles","year":"1983","unstructured":"Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau\u2019s syndrome revisited. Blood 62:14\u201331","journal-title":"Blood"},{"key":"1161_CR48","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199905203402007","volume":"340","author":"RD Rosenberg","year":"1999","unstructured":"Rosenberg RD, Aird WC (1999) Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 340:1555\u20131564","journal-title":"N Engl J Med"},{"key":"1161_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1538-7836.2007.02808.x","volume":"6","author":"A Sahni","year":"2008","unstructured":"Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW (2008) Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor2 (FGF-2). J Thromb Haemost 6:174\u2013175. doi: 10.1111\/j.1538-7836.2007.02808.x","journal-title":"J Thromb Haemost"},{"key":"1161_CR50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphner","year":"1991","unstructured":"Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286\u2013294","journal-title":"J Clin Oncol"},{"key":"1161_CR51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.ATV.0000065196.61663.8D","volume":"23","author":"PJ Talmud","year":"2003","unstructured":"Talmud PJ, Martin S, Steiner G, Flavell DM, Whitehouse DB, Nagl S, Jackson R, Taskinen MR, Frick MH, Nieminen MS, Kes\u00e4niemi YA, Pasternack A, Humphries SE, Syv\u00e4nne M (2003) Diabetes Atherosclerosis Intervention Study Investigators. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol 23:644\u2013649. doi: 10.1161\/01.ATV.0000065196.61663.8D","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1161_CR52","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ejca.2004.06.023","volume":"40","author":"ME Tesselaar","year":"2004","unstructured":"Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S (2004) Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 40:2253\u20132259. doi: 10.1016\/j.ejca.2004.06.023","journal-title":"Eur J Cancer"},{"key":"1161_CR53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm1196-1179","volume":"2","author":"P Tonin","year":"1996","unstructured":"Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Lynch HT, Lenoir GM, Narod SA, Garber JE (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179\u20131183","journal-title":"Nat Med"},{"key":"1161_CR54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.mrrev.2003.06.011","volume":"544","author":"K Trenz","year":"2003","unstructured":"Trenz K, Lugowski S, Jahrsd\u00f6rfer U, Jainta S, Vogel W, Speit G (2003) Enhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostatics. Mutat Res 544:279\u2013288. doi: 10.1016\/j.mrrev.2003.06.011","journal-title":"Mutat Res"},{"key":"1161_CR55","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1182\/blood.V82.12.3648.3648","volume":"82","author":"CA Vasconcellos","year":"1993","unstructured":"Vasconcellos CA, Lind SE (1993) Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood 82:3648\u20133657","journal-title":"Blood"},{"key":"1161_CR56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","volume":"116","author":"J Villanueva","year":"2006","unstructured":"Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116:271\u2013284. doi: 10.1172\/JCI26022","journal-title":"J Clin Invest"},{"key":"1161_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000276567","volume":"25","author":"JJ Zamorano-Le\u00f3n","year":"2010","unstructured":"Zamorano-Le\u00f3n JJ, Modrego J, Mateos-C\u00e1ceres PJ, Macaya C, Mart\u00edn-Fern\u00e1ndez B, Miana M, de las Heras N, Cachofeiro V, Lahera V, L\u00f3pez-Farr\u00e9 AJ (2010) A proteomic approach to determine changes in proteins involved in the myocardial metabolism in left ventricles of spontaneously hypertensive rats. Cell Physiol Biochem 25:347\u2013358","journal-title":"Cell Physiol Biochem"},{"key":"1161_CR58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1025761716283","volume":"81","author":"CC Zielinski","year":"2003","unstructured":"Zielinski CC, Budinsky AC, Wagner TM, Wolfram RM, K\u00f6stler WJ, Kubista M, Brodowicz T, Kubista E, Wiltschke C (2003) Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriers. Breast Cancer Res Treat 81:99\u2013105","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1161-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-012-1161-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1161-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:16:58Z","timestamp":1713485818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-012-1161-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,7]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s00432-012-1161-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,7]]}}}